Client News
OKYO Pharma Limited: Directorate ChangeOKYO Pharma Limited (“OKYO” or the “Company”) today announces that Bernard Denoyer has been appointed as a non-executive director of the Company with immediate effect.
Bernard F. Denoyer (age: 74)
Bernard F. Denoyer has 49 years of financial management experience including his service as Senior Vice President, Finance and Secretary of development stage Synergy Pharmaceuticals, Inc. (NASDAQ: SGYP) from July 2008 until FDA approval and his retirement in June 2017.
From January 2004 until January 2013. Mr. Denoyer concurrently served as Principal Financial Officer of Synergy’s former parent company, Callisto Pharmaceuticals, Inc., (OTCMKTS: CLSP). While with SGYP and CLSP he supported over $500M of public and PIPE financings with related due diligence, SEC registrations and market listings.
https://www.londonstockexchange.com/news-article/OKYO/directorate-change/15231935
OPEN AN ACCOUNT
If you are interested in opening an account with Optiva Securities, please fill in the details on the apply button.
CLIENT AREA
Please ensure that the information you entered is accurate, and that your “Caps Lock” key is set correctly.